<DOC>
	<DOCNO>NCT00773708</DOCNO>
	<brief_summary>This study aim provide new knowledge pathogenesis HIV infection , specifically , role immune activation apoptotic activity play immune recovery , particular , paradoxical immunologic response patient antiretroviral therapy despite achievement sustain complete viral suppression . In regard , investigator prospectively evaluate impact intensification Raltegravir `` discordants '' patient high index immune activation , measure percentage CD8+HLADR+CD38+ cell . This provide relevant information effectiveness drug guide intensification regimen .</brief_summary>
	<brief_title>Pilot Opened Trial HIV-infected Patients Including Investigational Marketed Product</brief_title>
	<detailed_description>One many adverse consequence human immunodeficiency virus ( HIV ) infection increase rate lymphocyte cell death ( Badley AD , Blood . 2000 ; 96:2951-64 ) . Increased lymphocyte death associate level activation immune system ( Gougeon ML . Nat Rev Immunol . 2003 : 3:392-404 ) , along disregulation cytokine network plethora cytotoxic effect induce HIV protein ( Badley AD , Blood . 2000 ; 96:2951-64 ) . Hence , cell death observe vivo CD4+ cell , main target HIV , also CD8 T cell . Current knowledge suggest immune activation different mechanism cell death play determinant role T-lymphocyte ( CD4+ ) loss HIV infection recovery HAART ( Bofill M et al AIDS . 1996 :827-34 ) . Highly active antiretroviral treatment ( HAART ) induce decline level immune activation lymphocyte apoptosis HIV-infected patient result reduction viral replication ( Kolber MA , et al , Clin Immunol . 2007 [ Epub ahead print ] ) . This reduction contribute recovery immune system associate antiretroviral therapy . In addition effect , induce reduction viral load , antiretroviral therapy implicate regulation apoptosis different cell type , inhibit activate process influence treatment efficacy toxicity ( Petit F , et al.Trends Pharmacol Sci . 2005 . 26:258-64 ) . Interestingly , always true antiretroviral therapy viral suppression associate progressive immune recovery . Approximately 30 % patient present paradoxical response treatment , achieve progressive increase immunity ( measure CD4+ count ) despite fail achieve viral suppression , , vice versa , patient maintain reduce CD4+ cell count despite achieve viral suppression . Indeed , well know high CD8 activation associate few treatment-mediated CD4 gain . Each 10 % increase activate CD8+HLADR+CD38+ mean 90 few CD4 cell gain ( Hunt PW et al J Infect Dis . 2003 . 187:1534-43 ) . The failure recover CD4 T cell may rely incomplete viral suppression could responsible increase immune activation lymphocyte death . Recently , point intensification strategy may useful reduce activation improve CD4 T cell recovery ( Kolber MA , et al , Clin Immunol . 2007 [ Epub ahead print ] ) .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>1 . Patient diagnosis HIV infection , continuously HAART least 2 year , include : 2 NRTI/NtRTIs ( except ddI+TDF ) , plus 1 PI/ritonavir ( lopinavir/ritonavir , atazanavir/ritonavir , fosamprenavir/ritonavir , tipranavir/ritonavir , darunavir/ritonavir ) 1 NNRTI ( nevirapine efavirenz ) 2 . Undetectable plasma HIV1 RNA ( VL &lt; 50 copies/mL ) last 2 year prior screen ( least 4 determination viral load time period ) . 3 . Good treatment adherence . 4 . No presence factor could contribute CD4+ decline , treatment chemotherapy , treatment interferon/ribavirin , ddI+TDFcontaining regimen , etc , least 12 month prior screen . 5 . Patient classify `` discordant '' show high level CD8+HLADR+CD38+ cell death value screen ( see reference value definition section page 9 : 4.2 . AIMS ) . 6 . Voluntary write informed consent . 1 . Pregnancy fertile woman willing pregnant . 2 . Acute infection uncontrolled chronic infection 2 month previous inclusion . 3 . Hepatic toxicity ( AST , ALT level grade +/= 3 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>Discordant patient</keyword>
	<keyword>CD4 recovery</keyword>
	<keyword>intensification antiretroviral therapy</keyword>
	<keyword>raltegravir</keyword>
	<keyword>HIV-1 infected patient classify `` discordant '' show high level CD8+HLADR+CD38+ cell death value screen</keyword>
</DOC>